Content
All Posts > Content under Pharma/Biotech
Recent Pot Warnings: Consider The Source(s)
Article By:
Rodney Johnson
Read
Tuesday, October 16, 2018 6:20 PM EDT
No matter what sort of warnings we hear from the powers that be,the facts tell us that this is a market to follow, so that’s what we’ll do. And...legal marijuana sales launch in Canada tomorrow.
West Pharma Brokers Say Its Future Is Grim. I Disagree.
Article By:
Fredrik Arnold
Read
Tuesday, October 16, 2018 5:28 AM EDT
West's price per share was $115.62 at yesterday's market close. A year ago its price was $95.67 for a price gain of $19.95 per share for the year.
In this article: WST
No More "Business As Usual" For Europe's Petrochemicals Companies
Article By:
Paul Hodges
Read
Sunday, October 14, 2018 9:17 AM EDT
Europe's petrochemical sector must prepare now for the combined impact of trade wars, new US polymer start-ups, the circular economy and Brexit. That was the clear message from last week's European Petrochemical Association meeting in Vienna.
Banks Provide Positive Start To Q3 Earnings Season
Article By:
Sheraz Mian
Read
Saturday, October 13, 2018 5:51 PM EDT
Bank stocks have been notable laggards in recent quarters, with market participants preferring the faster growing technology stocks to these seemingly boring companies. Banks are boring, but they have a lot going for them.
Week In Review: Biosense Exercises $75 Million Option For China Rights To Neovacs' Lupus Immunotherapy
Article By:
ChinaBio® Today
Read
Saturday, October 13, 2018 4:59 PM EDT
Biosense Global, a New Jersey-Suzhou in-licensing company, exercised a $75 million option for China rights to an active lupus immunotherapy developed by Neovacs, following a successful Phase II trial of the therapeutic vaccine, IFNalpha Kinoid.
Corium Announces Agreement For Gurnet Point Capital To Purchase All Outstanding Shares
Article By:
NASDAQ GlobeNewswire
Read
Friday, October 12, 2018 12:00 AM EDT
Total transaction valued in excess of $500 million, representing a 50% premium.
In this article: CORI
Walgreens (WBA) Q4 Earnings Top Estimates, Revenues Lag
Article By:
Zacks Investment Research
Read
Thursday, October 11, 2018 12:31 PM EDT
Walgreens Boots Alliance, Inc. WBA reported adjusted earnings per share (EPS) of $1.48 for fourth-quarter fiscal 2018, up 12.9% year over year (same at constant exchange rate). The figure surpassed the Zacks Consensus Estimate of $1.44.
A Drug Giant Whose Dividend Safety Isn’t As Bad As It Looks
Article By:
Marc Lichtenfeld
Read
Wednesday, October 10, 2018 7:30 PM EDT
Investors tend to buy large pharmaceutical companies because of their safety.
In this article: PFE
Altimmune Announces $25 Million Registered Direct Offering
Article By:
NASDAQ GlobeNewswire
Read
Monday, October 8, 2018 11:00 PM EDT
Altimmune, Inc. today announced it has entered into a purchase agreement with several institutional investors for the purchase of common units and pre-funded units for a combined total of 4,629,630 units in a registered direct offering.
In this article: ALT
The Week In Charts: Your Trading Success Might All Boil Down To This One Thing
Video By:
Dave Landry
Watch
Sunday, October 7, 2018 7:36 AM EDT
In this episode, Dave discusses how your trading success could boil down to just two words. And, last but not least, he fielded your trading questions and analyzed your favorite stock picks.
Week In Review: Shanghai Henlius To File For Hong Kong IPO At Valuation Of Over $1 Billion
Article By:
ChinaBio® Today
Read
Saturday, October 6, 2018 5:57 PM EDT
Shanghai Fosun Pharma announced it will seek a Hong Kong IPO for Shanghai Henlius Biotech, its monoclonal antibody JV subsidiary The company was established to develop mAb biosimilar drugs, bio-betters and novel mAbs.
